Transcriptomics Study of Neurodegenerative Disease: Emphasis on Synaptic Dysfunction Mechanism in Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|7|1202-1212

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.7, 2014-09, pp. : 1202-1212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of Electrophysiological Changes in Alzheimer's Disease: A Microarray Based Transcriptomics and Molecular Pathway Analysis Study

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 9, 2018-01 ,pp. : 1027-1038

Bentham Science Publishers

Access to resources Recommend Favorite

Key Role of Mitochondria in Alzheimer's Disease Synaptic Dysfunction

By  

Current Pharmaceutical Design, Vol. 19, Iss. 36, 2013-11 ,pp. : 6440-6450

Bentham Science Publishers

Access to resources Recommend Favorite

Tocopherol (Vitamin E) in Alzheimer’s Disease and Other Neurodegenerative Disorders

By Karen Berman   Henry Brodaty  

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 807-825

Adis International

Access to resources Recommend Favorite

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite